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Abstract
Cytochromes b561 (Cyts b561) are a family of intrinsic membrane proteins involved in ascorbate-mediated transmembrane electron transport.
The chromaffin granule Cyt b561 (CGCytb) is believed to transport electrons donated by extravesicular ascorbate (ASC) across the membrane to
intravesicular monodehydroascorbate (MDA) supporting catecholamine synthesis in neuroendocrine tissues. Another isoform, the duodenal Cyt
b561 (Dcytb), was reported to have ferric reductase activity, possibly facilitating intestinal iron uptake. Herein, a new Cyt b561 homologue, LCytb
(for lysosomal Cytb561) was found expressed in the late endosomal–lysosomal membrane. LCytb shared high sequence similarity with CGCytb
(45% identity) and Dcytb (42% identity). Moreover, four heme-coordinating His residues, and putative ASC and MDA binding sites were highly
conserved. Recombinant LCytb exhibited an ASC-reducible b-type Cyt absorbance spectrum with α-band maximum at 561 nm in the spectrum of
the reduced protein. Northern blots and Western blots revealed that LCytb was predominantly expressed in lung, spleen, thymus, testis and
placenta. In situ hybridization and immunofluorescence studies further demonstrated that the protein was expressed in the alveolar macrophages of
the lung, in the white pulp of the spleen, widespread in the thymus, and in the Sertoli cells of the testis. Sequence analysis indicated the presence of
a (DE)XXXL(LI)-type signal in the C-terminal of the protein, predicting a late endosomal–lysosomal subcellular localization. This localization
was confirmed by double labeling experiments in RAW264.7 and 293 cells, stably transfected with LCytb.
© 2006 Elsevier B.V. All rights reserved.
Keywords: Lysosomal cytochrome b561 (LCytb); Chromaffin granule cytochrome b561 (CGCytb); Duodenal cytochrome b561 (Dcytb); Macrophage, Lysosome

1. Introduction
Chromaffin granule Cyt b561 (CGCytb) is an intrinsic
membrane protein expressed in neuroendocrine tissues. CGCytb
is believed to function as an electron carrier transporting
electrons from extravesicular ASC to intravesicular MDA to
recycle ASC, supporting catecholamine synthesis [1]. It has only
recently become evident that CGCytb is a member of a newly
described protein family, ubiquitously present in almost all
living kingdoms [2]. Using the CGCytb protein sequence,
genome analysis has revealed the presence of multiple Cyt b561
⁎ Corresponding author. Department of Biology, University of Antwerp,
Groenenborgerlaan 171, B-2020, Antwerp, Belgium. Tel.: +32 3 265 3638; fax:
+32 3 265 3417.
E-mail address: han.asard@ua.ac.be (H. Asard).
0304-4165/$ - see front matter © 2006 Elsevier B.V. All rights reserved.
doi:10.1016/j.bbagen.2006.07.019

isoforms in many species, with, for example, five isoforms in
mice and four in Arabidopsis thaliana [2,3]. Although very little
is known about any of the other Cyt b561 isoforms, sequence
conservation suggests that they all have the structure motifs of
Cyts b561, i.e. six putative transmembrane domains, four His
residues which coordinate two heme molecules responsible for
electron transport, and two putative binding sites involved in
binding of ASC and MDA [2,4–6]. The sequence conservation
suggests that all members of the Cyt b561 protein family are
likely involved in ASC-mediated transmembrane electron
transport. However, the localization and importance of the Cyt
b561 isoforms other than CGCytb remain to be determined.
The so-called duodenal Cyt b isoform (Dcytb, or Dcybrd1)
was localized in the mouse duodenal apical brush-border
membrane [6]. Dcytb shared between 45% and 50% similarity
to other members of the Cyt b561 family [6]. Subtractive cloning
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and expression of the Dcytb gene in Xenopus oocytes revealed
that the gene encoded a protein with ferric reductase activity [6].
Dcytb-mediated reduction of ferric iron to ferrous iron is likely
to facilitate iron absorption in the duodenum by DCT1 (Divalent
cation transporter 1)/Nramp2 (Natural resistance-associated
macrophage protein 2) [7,8]. However, Gunshin et al. recently
reported that knockout of Dcytb had little or no impact on body
iron stores, even in animals with low iron diet. This indicates that
the role of Dcytb is far from clear [9,10].
Another Cyt b561 homologue, encoded by the gene 101F6, is
localized in a 120-kb critical tumor deletion region (found in lung
and breast cancers) of human chromosome 3p21.3 [11]. Forcedexpression of wild-type 101F6 in human lung cancer cell lines
significantly inhibited tumor cell growth by induction of apoptosis
and alteration of cell cycle processes [12]. Moreover, intratumoral
injection of Ad-101F6 significantly suppressed the growth of
tumor xenograft and inhibited experimental lung metastases in nu/
nu mice, but the underlying mechanism remains unknown [12].
As the Cyts b561 constitute a poorly characterized family of
membrane proteins, herein we investigated the properties and
the cellular and subcellular localization of another member of
this protein family identified by genome analysis. Our results
demonstrate that this Cyt b561 was localized predominantly in
the late endosomal–lysosomal membranes and the protein has
therefore been named LCytb.
2. Materials and methods
2.1. Plasmid constructs and yeast transformation
Standard PCR methods were used to amplify the gene (accession number:
NM_201351) encoding a putative new Cyt b561 from total mouse kidney RNA.
Primers were designed to include EcoRI and SpeI restriction sites for cloning into
the pESC-His expression vector (Stratagene, La Jolla, CA), downstream of the
GAL10 Gal-inducible promoter. For transformation, yeast cells (strain YPH499,
ura3-52 lys2-801amberade2-101ochre trp1-Δ63 his3-Δ200 leu2-Δ1) were
grown in YPAD medium (Stratagene, La Jolla, CA) and transformation was
performed according to the manufacturer's instructions. Transformed cell lines
were selected on SD dropout medium lacking His (SD-His). For the induction of
protein expression, overnight cultures were grown in SD-His and were
transferred to 450 ml of synthetic Gal minimal medium containing 2% (w v− 1)
Gal and supplemented with 1 mM ASC.

2.2. Plasmid constructs, cell culture and transfection
The mouse macrophage-derived cell line, RAW264.7 (ATCC) was cultured
in DMEM medium containing 100 units L− 1 penicillin, 100 units L− 1
streptomycin, 10% FBS at 37 °C under 5% CO2. 293 cells derived from
primary human embryonic kidney (GIBCO, Invitrogen Corporation) were
cultured in the same condition as the RAW264.7 cells, except that they were
supplemented with 0.1 mM non-essential amino acids. The LCytb gene was
cloned into pcDNA3.1-vector (Invitrogen Life Technologies) with XbaI and
EcoRI restriction sites, and transfected into the RAW264.7 and 293 cells
using the FuGENE-6 transfection reagent (Roche Applied Science). The stably
transfected cell clones were screened with G418 1 mg ml− 1 for RAW264.7 and
400 μg ml− 1 for 293 cells for 2 weeks.

remove loosely bound proteins and proteins trapped inside sealed membrane
vesicles, membranes were ‘stripped’ as follows: membrane fractions were
suspended in 10 ml storage buffer, after addition of 0.05 ml 5% (w v− 1) Triton X100 and 5 mM ASC, mixed vigorously and incubated on a rocker for 15 min at
room temperature. Then 10 ml of 2 M KCl was added, and the fraction was
incubated on the rocker for another 15 min. After addition of 20 ml nanopure H2O
the fraction was again incubated for 15 min on the rocker. Membranes were
collected by centrifugation at 75,000×g for 75 min at 4 °C, resuspended in
storage buffer (25 mM MES-Tris, pH 6.8, containing 1% (w v− 1) glycerol), and
stored at − 85 °C until use. Protein concentration was determined using a
modified Lowry method with BSA as the standard [14].

2.4. Animal organ microsomal membrane and cell lysate preparation
Animal organs (Pel-Freez biologicals, Rogers, AR) were homogenized in 10
volumes of ice-cold homogenization buffer (50 mM Tris–HCl pH 7.0, 150 mM
NaCl, 1 mM ASC, 2 mM EDTA, 1 mM PMSF, 1 μg ml− 1 each of leupeptin,
aprotinin, pepstain A, antipain, and chymostatin). Debris and unbroken cells
were removed by centrifugation at 5000 × g for 10 min, the supernatant was
centrifuged at 75,000 × g for 75 min at 4 °C to collect the microsomal
membranes, and pellet was resuspended in storage buffer. Stripping of the
membranes was performed as described for yeast membranes.
Spleen and lung tissues were homogenized in liquid nitrogen, and kept in
Munro's buffer (10 mM HEPES, pH 7.2, 3 mM MgCl2, 40 mM KCl, 5%
glycerol, 0.2% NP-40, 5 mM DTT, 1 mM AEBSF, 10 mg/ml Leupeptin and
CompleteTM EDTA free protease inhibitor cocktail (Roche Diagnostics)) for
15 min on ice. After centrifugation for 10 min at 13 000 × g, the supernatants
were kept for Western blot analysis. 293 cells transfected with LCytb or
pcDNA3.1-empty vector were cultured until the confluence reached 80%, the
cells were collected and rinsed with ice-cold PBS. Then the cell lysate was
prepared with lysis buffer (0.15 M NaCl, 5 mM EDTA, 1% Triton X-100,
100 mM Tris–Cl pH 7.4, 5 mM DTT, 1 mM PMSF, 1 μg ml−1 each of leupeptin,
aprotinin, pepstain A, antipain, and chymostatin). The sample was centrifuged at
5000 × g for 10 min; the supernatant was stored at − 80 °C until use. Alveolar
macrophages were prepared according to Holt's methods [15], the macrophages
lysate was prepared as described for 293 cell.

2.5. Measurement of Cyt b absorption spectra
Absorption spectra of membrane-bound Cyt b in stripped yeast microsomal
membrane vesicles were determined from oxidized and reduced spectra recorded
in dual wavelength-mode (between 500 and 600 nm and reference at 601 nm;
SLM-Aminco DW2000 spectrophotometer updated by OLIS Inc., Bogart, GA),
in 2 ml samples with 1 nm slit-width, 0.5 nm s− 1 scan rate, and under continuous
stirring. First, Cyts were oxidized by addition of ferricyanide (0.1 mM, FeCN) and
the fully oxidized spectra were recorded. Then, ASC-reduced (25 mM ASC) and
ASC + dithionite-reduced (after addition of Na-dithionite crystals) spectra were
obtained at room temperature. When improvement of the signal to noise ratio was
needed, multiple scans were averaged. In calculations, reduced minus oxidized
difference spectra and 30 mM− 1 cm− 1 as molar extinction coefficient at 561 nm
were used. The protein concentration was 2 mg ml− 1 throughout the experiments.

2.6. Northern blot analysis
A nylon (+) membrane blotted with 20 μg of total RNA in each lane from
each mouse organ was purchased from Seegene, Seoul, Korea. Northern blots
were performed according to the manufacturer's protocol. The template for the
LCytb probe consisted of the nucleotides from 570 to 662 bp of the mouse LCytb
cDNA, corresponding to the first 93 bp nucleotides of the coding sequence. The
single strand DNA probes were synthesized and labeled with 32P-dCTP by PCR
with antisense primer only. The membrane was hybridized with 32P-labeled DNA
probes at 58 °C for 16 h, and subjected to autoradiography for 24–72 h.

2.3. Yeast microsomal membrane preparation and stripping
2.7. Antibody generation, purification and western blots analysis
Yeast cells transformed with the LCytb gene or empty pESC-His vector were
cultured overnight or longer until the OD600 reached 0.6–0.8. The yeast
microsomal membrane fraction was prepared as reported previously [13]. To

Antibodies were generated in rabbit against a C-terminal peptide ([Cys]KRPDPGALTDRQPLLHDRE) of mouse LCytb. After screening the sera for
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the presence of LCytb-specific antibodies against yeast recombinant LCytb,
antibodies were affinity purified using Sulfolink Coupling Gel (Pierce
Biotechnology, Rockford, IL) according to the manufacturer's procedure.
Membrane proteins were resolved by SDS-PAGE electrophoresis, using 12%
acrylamide gels and transferred onto polyvinylidene difluoride membranes
(PVDF, Bio-Rad, Hercules, CA). Each well was loaded with 15 μg samples for
animal tissues and 1 μg sample for yeast recombinant LCytb. Prior to loading,
samples were incubated at 37 °C for 30 min to denature the sample. Boiling was
proved resulting in aggregation of the LCytb and preventing the protein from
entering into the gel. LCytb antibodies were used in a 1:200 dilution, and
protein–antibody complexes were detected by horseradish peroxidase-conjugated secondary antibodies (ECL detection kit, Amersham-Pharmacia
Biotech, Piscataway, NJ). For peptide N-glycosidase F (PNGase F) digestion,
aliquots of samples were digested with PNGase F according to manufacturer's
instruction (New England Biolabs Inc.), after denaturing for 30 min at 37 °C in
denaturing buffer.

2.8. Immunohistochemistry
Mouse organs removed from anesthetically killed animals were immediately
fixed in ice-cold buffered 4% paraformaldehyde for 48 h and cryoprotected in
30% sucrose/0.1 M PBS for 48 h. The organs were sectioned into 10 μm
sections, and then air-dried and stored at 4 °C until use. Sections were boiled in
citrate buffer (0.01 M, pH 6.4) with a microwave oven for 15 min for antigen
retrieval. Sections were incubated with the primary antibody for 2 h at RT or
overnight at 4 °C, and were incubated with the secondary antibody for 1 h at RT.
The sections were mounted with Gel Mount™ Aqueous Mounting Medium
(Sigma-Aldrich).
For immunocytochemistry, the cells cultured on cover glass were fixed
with ice-cold methanol for 5 min. For double-labeling with Lysotracker, the
cells were incubated with 100 nM Lysotracker Red DND-99 (Molecular
probes, Inc) in DMEM without serum for 30 min at 37 °C, then rinsed with
PBS and fixed in ice-cold buffered 4% paraformaldehyde for 10 min. The cells
were treated with 0.5% Triton X-100 for 15 min to increase their permeability.
The cells were labeled with primary antibodies for 2 h and secondary antibody
for 1 h at RT. The dilution was 1:50 for rabbit-anti-mouse LCytb, rat-antimouse MAC-3 and rat-anti-mouse Lamp2 (BD Biosciences, San Diego, CA),
was 1:60 for CY2 labeled donkey-anti-rabbit and CY5 labeled donkey-anti-rat
(Jackson ImmunoResearch Laboratories, West Grove, PA). The samples were
observed under a fluorescence microscope (Nikon Eclipse TE300), or a
confocal microscope (Olympus FV500).

2.9. In situ hybridization (ISH)
Sense and anti-sense cRNA probes were synthesized with the DIG RNA
labeling kit (SP6/T7) (Roche, Indianapolis, IN). A nucleotide in 93 bp, the
same region as used in the northern blot, was cloned into the plasmid
pSPT18/19 as a template to generate cRNA. ISH was performed on
cryosections (10 μm) with the SureSite® II system (Novagen, EMD
Biosciences) according to the manufacturer's protocol. The sections were
incubated with denatured sense or anti-sense cRNA probes (500 ng ml− 1 in
hybridization buffer) at 50 °C for 18 h. The hybridized probes were
visualized using anti-digoxigenin Fab fragments (dilution 1:500, Roche,
Indianapolis, IN) and BCIP/NBT substrate, and observed under a Nikon
Eclipse TE300 microscope.

2.10. RT-PCR
Total RNA was prepared from lung and alveolar macrophages with TRIzol®
reagent (Invitrogen life technologies) according to the manufacturer's protocol.
Two micrograms of RNA was used to prepare the cDNA. The following primers
were used in the PCR experiments: LCytb, left: 5′-ATGGCTTCAGGATGGTTT-3′, right: 5′-TCATTCCCTGTCATGCAA-3′, yield a product of
726 bp, beta-actin, left: 5′-CTGTATTCCCCTCCATCGTG-3′ right: 5′TACTCCTGCTTGCTGATCCA-3′, yield a product of 1000 bp. LCytb was
amplified for 27 cycles and beta-actin was amplified for 23 cycles. The PCR
products were separated in 1% agarose gel and taken picture with Gel Doc 1000
system (Bio-Rad).
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3. Results
3.1. LCytb is an ASC-reducible Cyt b561
A protein-protein BLAST search of the NCBI protein
database, using the bovine CGCytb sequence (NCB accession:
NP_031831) as a query, revealed the presence of five Cyt b561
homologs in the mouse genome. In addition to the mouse
CGCytb, these are Dcytb [6], 101F6 [12,16], and two proteins
with yet unknown function, Cyb561d1 (NCB accession:
XP_485295) and a hypothetical protein (NCB accession:
NP_958739). The latter is characterized in this study. Based
on its subcellular localization in the late endosomes and
lysosomes (see below), we named the new putative Cyt b561 as
LCytb.
Multiple sequence alignment of mouse Cyts b561 revealed
that LCytb shared high sequence similarity with CGCytb (45%
identity over 211 amino acids), Dcytb (42% identity over 217
amino acids), 101F6 (29% identity over 136 amino acids) and
Cyb561d1 (28% identity over 236 amino acids). LCytb was
also highly conserved among different mammals, with 92%
identity to rat putative LCytb (NCB accession: XP_342023),
84% identity to human putative LCytb (NCB accession:
AAH47710), and 83% identity to the chimpanzee putative
LCytb (NCB accession: XP_508473). Secondary structure
prediction suggested that LCytb is an intrinsic membrane
protein containing six consensus transmembrane domains (Fig.
1). Furthermore, LCytb has four conserved His residues most
likely coordinating two heme molecules, and two putative
binding sites for ASC and MDA. The N- and C-terminal ends of
the protein were predicted to be localized in the cytoplasm by
TMpred [17].
To identify whether LCytb is really a b-type Cyt, mouse
LCytb was expressed in yeast. Spectroscopic analysis using
microsomal membrane fractions from the transformed yeast
cells demonstrated the presence of an ASC-reducible b-type Cyt
(Fig. 2). In agreement with earlier observations [13], no ASCreducible Cyts was detected in the microsomal membrane
fraction from yeast cells transformed with the empty vector. The
α-band of the reduced Cyt b is asymmetrical, with a maximum
near 561 nm and a shoulder near 556–557 nm. The level of
ASC reduction is about 52% of the maximal reduction obtained
with Na-dithionite. The results therefore demonstrate that
LCytb is indeed an ASC-reducible b-type Cyt.
3.2. Expression of LCytb
To contribute to our understanding of the physiological
function of LCytb, we determined its organs and tissues
distribution and its subcellular localization. In Northern blot
analyses, the single strand DNA probe of LCytb hybridized
with two mRNA bands, one of 3.3 kb, ubiquitously expressed in
all organs tested, and another of 3 kb presented primarily in
lung, spleen, thymus, testis, placenta (17.5 d.p.c.), small
intestine, and stomach (Fig. 3). Comparing the density of the
bands, the highest expression levels of LCytb were observed in
lung, spleen, thymus, testis and placenta (17.5 d.p.c.). In
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Fig. 1. Multiple sequence alignment of LCytb with other mouse Cyt b561 isoforms. The sequence data for the Cyts were obtained from the NCBI protein database, and
their alignment was determined with ClustalX (1.8). The transmembrane domains (TMDs) were predicted with HMMTOP 2.0. As other Cyts b561s, LCytb is
predicted to contain six TMDs (TMD1 through TMD6, underlined). Four conserved His (indicated by arrow heads) likely coordinating two heme molecules and
putative binding sites for ASC and MDA (boxed) were conserved in the LCytb sequences. The “DRQPLL” signal peptides (double underlining) are putative (DE)
XXXL(LI)-type signals, potentially targeting the protein to late endosomes and lysosomes.

comparison, CGCytb was expressed at high levels in brain,
lung, kidney, stomach, intestine, testis, unpregnant uterus and
placenta (17.5 d.p.c.), and at lower levels in heart, spleen,
skeletal muscle and thymus (Fig. 3). The presence of two

Fig. 2. Reduced-minus-oxidized absorption spectra of recombinant mouse
LCytb in yeast microsomal membranes. The absorption spectrum of LCytb
exhibited a α-band spectrum, with a maximum at 561 nm. The level of ASC
reduction at 25 mM ASC was about 52% of the level reached with dithionite
(2 mM). No b-type Cyts were detected in the microsomal membrane fraction
of yeast cells transformed with the vector only (pESC). Protein concentration:
2 mg ml− 1.

transcripts for LCytb can possibly be explained by alternative
splicing (see Discussion).
Affinity-purified polyclonal antibodies generated against a
C-terminal peptide of LCytb were used to investigate the
presence of the LCytb protein in various mouse organs. A band
of about 27 kDa was detected on Western blots using
microsomal membrane fractions from lung, spleen, thymus
and testis. This band corresponds to the predicted mass of
LCytb (27.08 kDa), and to the mass of recombinant LCytb
expressed in yeast (Fig. 4A). In the yeast recombinant LCytb
sample, a band around 40 kDa also was detected. This band

Fig. 3. Northern blot analysis of the expression of LCytb in different mouse
organs. A nylon (+) membrane blotted with 20 μg total RNA each lane for
different mouse organs was hybridized with 32P-dCTP labeled LCytb cDNA
probe corresponding to the first 93 bp nucleotides of the LCytb encoding region.
CGCytb, 18S and 28S rRNA were used as loading control.
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Fig. 4. Western blot analysis of the expression of LCytb protein. (A) Expression of LCytb in microsomal membrane fractions of lung, spleen, thymus and testis was
detected with an affinity purified C-terminal peptide antibody. Yeast recombinant mouse LCytb was used as a positive control. (B) The specificity of the antibody was
assayed with fresh prepared membrane fractions of yeast transformed with mouse LCytb, CGCytb, Dcytb, or vector only. (C) Expression of LCytb in lysates of 293
cell transfected with LCytb or vector only. (D) Lysates of LCytb-transfected 293 cell and microsomal membrane fractions of lung were treated with PNGase F to check
the possibility of glycosylation.

might result from protein aggregation after repeated freezing
and thawing of the sample, since there was little if any of this
band detected in fresh sample (Fig. 4B). The affinity-purified
antibody did not cross-react with any of the other mouse Cyts
b561 when expressed in yeast, demonstrating that it was
isoform-specific (Fig. 4B). No or little LCytb protein could be
detected in microsomal membrane preparations from other
mouse organs such as brain, heart, liver and kidney (results not
shown). A smear of higher molecular mass bands (35–45 kDa)
was also observed in the Western blots from membrane
fractions of lung, spleen and thymus (Fig. 4A). In contrast to
that, in the testis, a band of about 29 kDa was also detected (Fig.
4A). In the cell lysate of LCytb-transfected 293 cells, a 27 kDa
band, a 29 kDa band, and a smeared band at about 35–45 kDa
were observed (Fig. 4C). These results demonstrated that these
bands in the microsomal membrane fractions of the various
mouse organs, specifically resulted from the LCytb expression.
Glycosylation of the intrinsic membrane protein DCT1/Nramp2
was reported to cause a smeared band at high molecular mass
[18]. Hence, we speculated that glycosylation could also be the
cause of the smeared bands observed in the organ membrane
fractions. After the LCytb-transfected 293 cell lysate was
treated with PNGase F, the band smear and the 29 kDa band

almost completely disappeared, while the 27 kDa band was
strengthened, which suggested that the 29 kDa band and the
band smear result from the glycosylation of the 27 kDa band
(Fig. 4D). The effect of glycosylation was also confirmed by the
treatment of lung membrane fractions with PNGase F, which
resulted in the disappearance of the band smear and enhancement of the 27 kDa band.
3.3. Tissue localization of LCytb
To determine the tissue localization of LCytb, we performed
ISH and immunofluorescence experiments. The anti-sense
cRNA probe specifically labeled particular cell-types in the
lung, spleen, thymus and intestine (Fig. 5A). Most of the positive
cells in the lung are localized in the alveolus, and a smaller
number of positive cells is located in the bronchia (arrow head in
Fig. 5Aa). The positive cells in the spleen are mainly localized in
the germinal center of the white pulp (Fig. 5Ac). In the thymus,
the labeled cells were almost evenly distributed throughout the
organ (Fig. 5Ae). In the intestine, a few cells in the lamina
propria of the villi were specifically labeled (Fig. 5Ag).
Immunofluorescence studies, using the same C-terminal
peptide antibodies used in the Western blots revealed similar
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Fig. 5. Distribution patterns of LCytb and CGCytb in different mouse organs. (A) In situ hybridization (ISH) analysis of the LCytb expression in different mouse
organs. Tissue sections from lung (a), spleen (c), thymus (e) and intestine (g) were labeled by the DIG-antisense cRNA probe, and sequential sections (b, d, f, h) were
labeled by the DIG-sense cRNA probe as a control. (B) Immunofluorescence analysis of the localization of LCytb in different mouse organs. Sections, from lung (a),
spleen (c), thymus (e), intestine (g) and testis (i), respectively, were probed with LCytb C-terminal peptide antibodies, and the antibody–protein complexes were
labeled by CY2-donkey anti-rabbit antibody (Green). In the sequential sections from the corresponding tissue (b, d, f, h and j), antibody-cross reaction was blocked
with the peptide demonstrating specificity of the antibody. The red color was from autofluorescence. a1 shows the lung alveolar region, and a2 shows the lung
bronchial region. The results are representative of three experiments. The bar in the figure represents 50 μm. (For interpretation of the references to colour in this figure
legend, the reader is referred to the web version of this article.)

distributions as observed with the ISH. Cells labeled in the lung
were mostly evenly distributed in the alveolar region and
appeared to be associated with the wall of the alveolus (green,

Fig. 5Ba1). A few labeled cells were localized in the bronchia
(Fig. 5Ba2), while there were no cells labeled in the blood vessel
(BV). Comparatively more cells were labeled in the spleen than
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in the lung (Fig. 5Bc). As was also observed with the ISH, these
were mainly localized in the germinal center of the white pulp,
and a few cells were labeled in the red pulp. The positive cells
observed in the thymus were more or less evenly distributed
throughout the organ, with slightly more cells labeled in the
medulla (Fig. 5Be). A few cells were specifically labeled in the
lamina propria of the villi of the intestine (Fig. 5Bg). In the testis,
the antibody very specifically labeled Sertoli cells (Fig. 5Bi).
However, the fluorescence level in these sections was lower than
that in other tissues. To demonstrate the specificity of the
antibody, the antibody were preincubated with the C-terminal
LCytb peptide before being added to the section, no labeling was
found in these sections (Fig. 5Bb, d, f, h and j). A few labeled
cells were also found in the cortex, but not in the medulla of the
kidney (results not shown). Several other organs were also tested
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for the presence of the LCytb protein but generally showed no
specifically labeled cells (e.g. in brain, heart, liver). In general,
the organ localization pattern of the LCytb protein obtained by
immunofluorescence corresponds very well to the distribution of
the LCytb mRNA obtained by ISH.
3.4. Identification of the cell type expressing LCytb
It is clear from the organ localization studies, that LCytb is
expressed in specific cell types, such as the Sertoli cells in the
testis, and in a well-defined cell type in the lung. As we
suspected the positive cells in the lung to be macrophages, we
simultaneously labeled lung sections with the LCytb antibody
(Fig. 6A, a, d, green) and the macrophage marker Mac-3
(Fig. 6A, b, e, red) [19]. The merge of the images obtained

Fig. 6. Localization of LCytb to alveolar macrophages. (A) Double fluorescence labeling of lung sections with LCytb and macrophage marker antibodies. Lung
sections were double labeled with LCytb antibodies (green) (panels a and d) and a macrophage marker, Mac-3 (red) (panels b and e). The pictures in the first row show
the alveolar region, the pictures in the second row show the bronchial region. Panels c and f are the merges of a/b and e/f, respectively. (B) Western blot analysis of
LCytb protein level in the lysate of alveolar macrophages (30 μg), in the microsomal membrane fractions of lung (15 μg), and in the homogenates of lung (30 μg) and
spleen (30 μg). The yeast-recombinant mouse LCytb (1 μg) was used as a positive control. (C) RT-PCR analysis to compare the LCytb mRNA level in alveolar
macrophages and lung, beta-actin mRNA level was used as loading control. These results are representative of three experiments.
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with the two antibodies (Fig. 6A, c and f) demonstrated that
LCytb was specifically and exclusively expressed in the
alveolar macrophages. A marker for type II pneumocytes, SPB (Surfactant-associated protein B) was also applied to these

sections, but no overlap between SP-B and LCytb was
observed.
In order to confirm the above results, alveolar macrophages
were isolated, and the expression of LCytb protein in the lysate

Fig. 7. Subcellular localization of LCytb in RAW264.7 and 293 cells. Double-labeling experiments analyzed the subcellular localization of LCytb in macrophagederived cell lines, RAW264.7 (A) and 293 (B), stably transfected with mouse LCytb. (A) Top row: fluorescence in cells labeled with anti-LCytb antibodies (green),
anti-Lamp2 antibodies (red), and the merge of these images. Bottom row: fluorescence in cells labeled with anti-LCytb antibodies, Lysotracker (red), and the merge of
these images. (B) Top row: fluorescence in cells labeled with anti-LCytb antibodies, Lysotracker and the merge of these images. Bottom row: higher magnification of
the boxed regions in the top row images. The blue signal is the result from nucleotide labeled by DAPI.
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of alveolar macrophages was compared with that in the
microsomal membrane fractions of LCytb-transfected yeast
and lung, and that in the homogenates of spleen and lung (Fig.
6B). In the alveolar macrophages lysate, the antibody detected a
27 kDa band and a 35–45 kDa smear of bands, the band and the
smeared bands were in the same pattern as that found in the
microsomal membrane fractions of lung (Fig. 4). In contrast to
alveolar macrophages lysate, the antibody detected very weak,
if any, smeared bands at 35–45 kDa in the homogenates of lung
and spleen (Fig. 6B). Considering that the intensity of the bands
in the alveolar macrophages lysate was comparable to that in
microsomal membrane fractions of LCytb-transfected yeast,
and was much stronger than that in the microsomal membrane
fractions of lung. The results suggested that LCytb is
specifically expressed in alveolar macrophages. In accordance
with the double labeling (Fig. 6A) and western blot results (Fig.
6B), the LCytb mRNA level is much higher in alveolar
macrophages than that in lung (Fig. 6C).
3.5. Subcellular Localization of LCytb
We found that the C-terminal end of the mouse LCytb
contained the peptide “DRQPLL” (Fig. 1, double-underlining).
This motif was also highly conserved in the LCytb sequences
from other mammals, but was absent from the other Cytb 561
isoforms. “DRQPLL” is a putative dileucine-based sorting
signal, that belongs to the (DE)XXXL(LI)-type signal family
[20]. These signals target membrane proteins to the late
endosomes and lysosomes, as well as to specialized endosomal–lysosomal compartments. The “DRQPLL” motif was
located at the C-terminal of LCytb, 11 amino acid residues
away from the TMD6, consistent with the general location of
the (DE)XXXL(LI)-type signals [20]. Moreover, the Pro
residue is also partially conserved in these signals [20]. The
presence of this motif indicated that LCytb might be localized in
the membrane of the late endosomes and lysosomes.
Since the expression level of the endogenous LCytb was low
in cell lines, the subcellular localization of LCytb was studied in
the RAW264.7 and 293 cells stably transfected with the mouse
LCytb gene, using double-labeling fluorescence (Fig. 7). Two
markers were used to determine the subcellular localization of
LCytb, respectively, an antibody against Lamp2 (Lysosomalassociated membrane protein 2), and the so-called Lysotracker,
a weakly basic amine selectively accumulating in cellular
compartments with low internal pH. In the LCytb transfected
RAW264.7 cell (Fig. 7A, upper panel), the fluorescence from
the LCytb antibody (green) overlapped closely with that from
Lamp2 (red). Similar results were obtained when the
RAW264.7 cells were co-labeled with the LCytb antibodies
and lysotracker (red) (Fig. 7A, lower panel). To verify these
results, the localization of LCytb was studied in the stably
transfected 293 cell line (Fig. 7B). Fluorescence of the LCytb
antibody and lysotracker appeared located in discrete particles,
and the two distributions patters overlapped very well (Fig. 7B,
upper panel). In a higher magnification of the merged images, it
was observed that the lysotracker accumulated into small
particles, which appeared surrounded by the fluorescence from

1911

the LCytb antibodies (Fig. 7B, lower panel). These results
strongly suggested that LCytb is localized in the late
endosomal–lysosomal membrane, and confirmed the localization predicted by the signal peptide.
4. Discussion
Cytochromes b561 are a family of intrinsic membrane
proteins, involved in ASC-driven transmembrane electron
transport. Although CGCytb, the first member identified in
this family, has been studied for almost 30 years, there is little
known about the other members of this protein family. In this
work, a new Cyt b561 isoform, LCytb, was studied with
Northern blot, Western blot, ISH and immunofluorescence.
LCytb has high sequence similarity with the other Cyt b561
isoforms (identity from 28% to 45%), it is also conserved in
different mammals (identity from 83% to 92%). Moreover,
LCytb has all of the structural elements found in Cyts b561. As
other Cyts b561, LCytb has six predicted transmembrane
domains, probably with the N- and C-termini in the cytoplasma
(Fig. 1) [17]. Two fully conserved pairs of His residues (H47–
H117 and H83–H156) are predicted to coordinate two heme
molecules on opposite sides of the membrane respectively,
conferring the property of transmembrane electron transport on
the protein. The putative ASC and MDA binding motifs are
conserved in LCytb, suggesting that LCytb could possibly
utilize ASC and MDA as electron donor and acceptor [4].
Expression of the mouse LCytb gene in yeast demonstrated that
this protein was indeed an ASC-reducible b-type Cyt, with a αband spectra almost identical to that of yeast recombinantCGCytb and bovine CGCytb [13] (Fig. 2).
To start to understand the physiological role of this new Cyt
b561, we performed tissue and cellular localization studies.
Northern blot analyses, using a LCytb-specific probe corresponding to the 5′-terminus of the encoding region, demonstrated a
3.3 kb band ubiquitously present in all of the organs tested and a
3 kb band primarily present in lung, spleen, thymus, testis and
placenta (Fig. 3). The two bands are possibly derived from
alternative splicing. It is noteworthy that we were only able to
detect the LCytb protein by immunofluorescence in the organs
that showed the 3 kb band, which suggests that alternative splicing
might result in the loss of the C-terminal epitope used to generate
the antibody. The organ distribution pattern of LCytb is very
different from those of two other Cyts b561, CGCytb and Dcytb.
CGCytb was mainly found in the adrenal medulla, the pituitary
gland and other neuroendocrine tissues [21–23], while Dcytb was
mainly found in the duodenum and was possibly present in spleen,
liver, brain, leucocytes, erythrocytes and neutrophils [6,24,25].
The purified polyclonal antibody generated against a Cterminal peptide detected three bands, including a 27 kDa band
(present in the samples of lung, spleen, thymus and testis), a
stronger smeared band (present in the samples of lung, spleen
and thymus), and a 29 kDa band (present only in testis) (Fig. 4).
Deglycosylation treatment with PNGase F indicated that the
smeared bands and the 29 kDa band resulted from glycosylation
of the 27 kDa protein. Therefore, the 27 kDa band could
represent the premature form of LCytb, in the process of
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maturation it is subject to different glycosylation, and the
glycosylation for the protein in testis is different from that in
other tissues. Because of differences in glycosylation, the
protein might be endowed with different function or different
compartmentalization, and this warrants further investigation.
To investigate the distribution of LCytb in tissues and
organs, ISH and immunohistochemistry experiments were
applied and yielded consistent results. In lung, LCytb was
found expressed in the bronchial and alveolar region, double
labeling with Mac-3 suggested that LCytb is expressed in a
specific cell type in this organ, alveolar macrophages. In testis
LCytb was specifically localized in Sertoli cells. The expression
of LCytb in macrophages and Sertoli cells was confirmed in
thioglycollate-elicited peritoneal macrophages, in the macrophage-derived cell lines, J774a.1 and RAW264.7, and in the
Sertoli cell line MSC-1, using of RT-PCR and immunocytochemistry techniques (unpublished data). LCytb was also found
expressed in the white pulp of spleen, in the lamina propria of
the intestinal villi, and in thymus, however, the cell type
expressing LCytb in these tissues is not known yet. It is
remarkable that in an organ that expresses two distinct Cyt b561
isoforms, such as the intestine, expressing Dcytb and LCytb,
these proteins are found in different regions. Dcytb is restricted
to the brush border membrane [6], whereas LCytb is found in
the lamina propria of the villi (Fig. 5g).
The C-terminal portion of LCytb contains a (DE)XXXL(LI)type signal peptide, putatively targeting the protein to late
endosomal–lysosomal membranes. This speculation is supported by double-labeling experiments, using stably transfected
macrophage cell line, RAW264.7 and 293 cell line (Fig. 7). The
localization of LCytb to the lysosomal membrane is remarkably
consistent with the localization of other Cyts b561 that have
been studied so far, to membranes separating an acidic and
neutral compartment. CGCytb is localized in chromaffin
vesicles with an acidic interior pH [26,27], Dcytb is localized
in the plasma membrane of cells lining the acidic intestinal
lumen [6], and a plant Cyt b561 (AtCytb1) has recently been
localized to the vacuolar membrane, separating the acidic
vacuolar content from the cytoplasm [28]. It has been argued
that the existence of pH and charge gradients over the
chromaffin vesicle membrane facilitates the electron transfer
mediated by CGCytb from cytoplasmic ASC to MDA in the
vesicle lumen [29]. It seems likely that similar pH gradients
support the activity of the other members of this protein family.
As other Cyts b561, the electron donor for LCytb probably is
cytoplasmic ASC, which is supported by the conserved ASC
binding site in the loop toward the cytoplasm (Fig. 1) and by the
reduction of yeast recombinant LCytb by ASC (Fig. 2). The
electron acceptor for LCytb is not known yet, considering the
sequence similarity, LCytb might have similar electron acceptor
as its homologs. It could be MDA as that of CGCytb, in this
case LCytb should have the ability to recycle ASC inside the
late endosomes and lysosomes. Another possible electron
acceptor could be the ferric ion as is likely for Dcytb. Ferric
reductase activity for LCytb has indeed recently been demonstrated by expressing the protein in yeast cells [30]. It is notable
that also CGCytb was recently reported to have ferric reductase

activity, and ferric reductase activity also was predicted for
other isoforms of Cyts b561 [3,31].
Iron is an essential nutrient for almost all organisms,
involved in a series of metabolic processes including electron
transport, DNA synthesis, ATP production and cell division.
Because of the low solubility of ferric ion, ferrous ion is the
biologically available form, and ferric ion has to be reduced into
ferrous ion for transporting by DCT1/Nramp2 that is localized
in membranes of different cell types, such as apical membrane
of duodenal enterocytes and endosomal membrane of macrophages [32,33]. For duodenal enterocytes, it probably is Dcytb
that reduces the ferric ion into ferrous to facilitate the transport
by DCT1/Nramp2 [6]. Dcytb displays ferric reductase activity
when it is expressed in Xenopus oocytes and yeast cells, and its
expression is up-regulated by iron-deficient diet and downregulated by iron-replete diet in mice, similar as DCT1/Nramp2
[6,24]. For macrophages, an unknown ferric reductase localized
in the endosomal membrane was suggested [7,8,34]. Therefore,
LCytb could very well be a candidate for this ferric reductase
facilitating Nramp2/DCT1-mediated transfer of iron into the
cytoplasm.
In conclusion, LCytb, a new isoform of ASC-reducible Cyts
b561, is described here. It is mainly expressed in the lung,
spleen, thymus, intestine and testis. LCytb expressed specifically in the alveolar macrophages of lung, and also expressed in
the Sertoli cells of testis. Signal peptide analysis and
fluorescence studies suggested that LCytb is localized in the
membranes of late endosomes and lysosomes.
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